Stage IVA Prostate Cancer
4 clinical trials · Condition
◉ Watch Stage IVA Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT03805594) | University of California, San Francisco | 2019-05-10 |
| Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer (NCT03880422) | Roswell Park Cancer Institute | 2019-05-02 |
| Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer (NCT03827473) | University of Utah | 2019-02-08 |
| Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer (NCT03477864) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-12-24 |
Track Stage IVA Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.